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Previous studies suggested that cigarette smoking 1) in-
hibits an increase in coronary blood flow that should
occur with increased myocardial oxygen demands, and
2) alters thromboxane and prostacyclin production,
causing vasoconstriction and platelet aggregation. In 38
smokers (26 men and 12 women, aged 50 ± 8 years
[mean ± standard deviation]) with coronary artery dis-
ease, systemic and coronary hemodynamic and serologic
variables were measured before and after smoking two
cigarettes (in 8 to 10 minutes) (21 patients) or 8 to 10
minutes without smoking (17 patients; control group).
No variable changed in the control group. Smoking in-
creased (p < 0.05) heart rate-systolic pressure product,
cardiac output and maximal first derivative of left ven-
tricular pressure (dP/dt) without significantly changing
the coronary sinus concentrations of thromboxane B2 or
6-keto-prostaglandin F1" (the stable metabolites of
thromboxane A2 and prostacyclin, respectively). Smok-
ing did not increase coronary flow in 6 of 11 patients
with greater than 70% stenosis of the proximal left an-
terior descending or circumflex coronary artery, or both,
In healthy experimental animals and human volunteers, cig-
arette smoking or parenterally administered nicotine in-
creases heart rate, systemic arterial pressure, cardiac output
and coronary blood flow (1-12), at least partly because of
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whereas it caused an increase in coronary flow in all 10
patients without proximal stenoses (p = 0.006). To de-
termine if smoking altered the response of coronary flow
to increased myocardial oxygen demands, 10 smokers
(5 men and 5 women, aged 48 ± 9 years) underwent
atrial pacing for 5 minutes followed 15 minutes later by
atrial pacing for 5 minutes during smoking. In the five
patients without proximal left coronary artery stenoses,
coronary flow increased 26 ± 29 mllmin with pacing
and 45 ± 21 ml/min with pacing/smoking (p = 0.018).
In contrast, in the five patients with proximal stenoses,
coronary flow increased 39 ± 24 mllmin with pacing,
but only 36 ± 16 mllmin with pacing/smoking (p =NS).
Thus, in smokers with coronary artery disease, smoking
increases myocardial oxygendemands. However, in some
individuals with severe proximal stenoses of the left coro-
nary artery, it may induce no change or cause a decrease
in coronary blood flow. The net effect of smoking on
coronary blood flow appears to be influenced by the
location and severity of atherosclerotic coronary artery
disease.
augmented concentrations of circulating catecholamines (13).
In animals with experimentally induced coronary athero-
sclerosis and in patients with coronary artery disease, smok-
ing also increases heart rate and systemic arterial pressure
(10,14-16), but its effects on coronary blood flow have not
been fully characterized. In fact, in individuals with coro-
nary atherosclerosis, some studies (7,14) have suggested
that coronary blood flow is not altered by smoking (although
myocardial oxygen demands are augmented). More recent
investigations (17-19) have even demonstrated that ciga-
rette smoking may cause a decrease in coronary blood flow
and a concomitant increase in coronary vascular resistance,
especially in individuals with severe proximal stenosis of
the left coronary artery (18). In these patients, therefore,
smoking may induce an imbalance between myocardial ox-
ygen supply and demand by increasing oxygen utilization
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in the setting of limited oxygen delivery. As a result, the
patient's anginal threshold is temporarily reduced (17,20).
Platelet aggregation is chronically increased in smokers ,
and smoking acutely renders platelets more responsive to
various proaggregatory stimuli (21). In the experimental
animal, nicotine depresses the formation and release of pros-
tacyclin (an endogenous vasodilator and inhibitor of platelet
aggregation produced by vascular endothelial cells) without
exerting a discernible effect on thromboxane (the powerful
vasoconstrictor and promoter of platelet aggregation produced
by aggregating platelets) (22-24). In long-term smokers,
the coronary sinus concentrations of 6-keto-prostaglandin
Fl a (6-keto-PGF 1a ) (the stable metabolite of prostacyclin)
are reduced in comparison with levels in nonsmokers (19).
As a result of this smoking-induced thromboxane/pro-
stacyclin "imbalance," vasoconstriction and platelet ag-
gregation within the coronary artery system may be en-
hanced, leading to a diminution in myocardial blood flow.
The present study was performed to: I) assess the sys-
temic and coronary hemodynamic responses to cigarette
smoking in long-term smokers with atherosclerotic coronary
artery disease, 2) examine the effects of smoking on the
intracoronary concentrations of thromboxane and prosta-
cyclin, and 3) evaluate the interrelations (if any) among the
hemodynamic and serologic alterations induced by smoking.
Methods
Patients
From February to October 1983, a total of 48 patients
(31 men and 17 women, aged 31 to 65 years) who underwent
cardiac catheterization for the evaluation of chest pain at
Parkland Memorial Hospital were studied after informed
consent had been obtained. All had smoked at least 10
cigarettes a day for longer than 10 years. At the time of
selective coronary arteriography, all had greater than 70%
luminal diameter narrowing of at least one major epicardial
coronary artery (one vessel in 15 patients, two vessels in
14 and three vessels in 19). None of the patients had received
glucocorticosteroids or cyclooxygenase inhibitors for at least
10 days before study. Before catheterization, there was no
attempt to control or alter antianginal medications, but care-
ful records were maintained of all nitrates, beta-adrenergic
blocking agents and calcium antagonists administered within
I week of study. In all patients, the experimental protocol
was performed in the fasting state after premedication with
oral diazepam, 10 mg. All hemodynamic measurements and
blood sampling were performed before systemic heparini-
zation, left ventriculography and selective coronary arteri-
ography. All subjects had refrained from smoking for at
least 4 hours before study.
Hemodynamic and Serologic Responses to Smoking
Experimental protocol. In 38 patients (26 men and 12
women, aged 50 ± 8 years [mean ± standard deviationl),
hemodynamic measurements and blood sampling were per-
formed in the baseline state and after random assignment
to (a) the smoking of two cigarettes (within 8 to 10 minutes)
(0 = 21) or (b) an 8 to 10 minute period without smoking
(n = 17) (control subjects). In these patients systemic ar-
terial pressure was recorded through a percutaneous femoral
artery cannula. Left ventricular pressure was recorded with
a high fidelity micromanometer-tipped pigtail catheter (Mil-
lar Instruments) advanced to the left ventricle from the fem-
oral artery, and the maximal first derivative of left ventric-
ular pressure (dP/dt) was electronically derived from this
pressure tracing. Cardiac output was measured with a flow-
directed, balloon-tipped thermodilution catheter (Electron-
ics for Medicine model 62 00 37) advanced to the pulmonary
artery from the femoral vein . An average of three ther-
modilution measurements of cardiac output was used for
the final computations. The variability of thermodilution
measurements in our laboratory is ± 4%.
In each patient, a 7 or 8 French woven Dacron (Goodale-
Lubin) catheter was advanced to the coronary sinus from
the right basilic vein. Its position was confirmed oximetr-
ically and by the injection of 3 to 5 ml of contrast material.
Samples of coronary sinus blood were obtained, and the
catheter's position within the coronary sinus was carefully
noted . Subsequently, the Goodale-Lubin catheter was re-
moved and a thermodilution catheter (Wilton Webster Lab-
oratories, model CCS-7U-90B) was advanced to the coro-
nary sinus through the same vein, after which its position
within the coronary sinus also was confirmed oximetrically
and fluoroscopically. Coronary sinus blood flow was mea-
sured with the continuous thermodilution technique (25) in
the baseline state and after smoking or an 8 to 10 minute
waiting period. During this 8 to 10 minute period, the ther-
modilution catheter was not moved or manipulated. Sub-
sequent to all measurements of coronary sinus blood flow,
the thermodilution catheter was removed and the Goodale-
Lubin catheter was reintroduced and advanced to the coro-
nary sinus where a careful attempt was made to position it
as closely as possible in its previous location relative to
adjacent radiopaque structures (such as the vertebral column
and ribs). Once this catheter was satisfactorily placed in the
coronary sinus, sampling of blood again was accomplished.
Chemical analyses. The blood specimens for throrn-
boxane B2 and 6-keto-PGFla analysis were drawn into hep-
arinized plastic syringes and transferred quickly into iced
10 ml tubes containing indomethacin (\0 J,Lg) and heparin
1,000 units). They were immediately centrifuged at 2,000
g for IS minutes at 4°C. The supernatants were separated
and stored at - 20°C for subsequent analysis. Thromboxane
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B2 and 6-keto-PGF1a were measured by radioimmunoassay
(26).
Analysis of data. All results are reported as mean ± 1
standard deviation. On the basis of the results of selective
coronary arteriography, the 21 patients who smoked during
the study were divided into those with (n = 11) or without
(n = 10) greater than 70% luminal diameter narrowing of
the proximal third of the left anterior descending or circum-
flex coronary artery, or both. Changes occurring from base-
line to repeat study (8 to 10 minutes later) within each group
(control group, smokers with proximal stenoses and smokers
without proximal stenoses) were evaluated using a paired t
test (27). The three groups were compared using an analysis
of variance (27). The patients with and without severe prox-
imal stenoses of the left coronary artery in whom smoking
failed to increase coronary sinus blood flow were compared
using a chi-square analysis (27). For all analyses, a prob-
ability (p) value of less than 0.05 was considered significant.
Effect of Smoking on Pacing-Induced Increases in
Coronary Sinus Blood Flow
Experimental protocol. In 10 patients (5 men and 5
women, aged 48 ± 9 years), heart rate, systemic arterial
pressure and coronary sinus blood flow were measured be-
fore and during rapid atrial pacing, and before and during
rapid atrial pacing during smoking. Specifically, a percu-
taneous femoral artery cannula was inserted for the mea-
surement of arterial pressure, and a thermodilution pacing
catheter was positioned in the coronary sinus. Baseline re-
cordings were accomplished, after which rapid atrial pacing
was performed for 5 minutes at 120 beats/min. Heart rate,
arterial pressure and coronary sinus blood flow were mea-
sured during the final 2 minutes of this pacing period. Sub-
sequently, atrial pacing was discontinued.
After a 15 minute delay, baseline recordings were re-
peated. Next, rapid atrial pacing was performed in an iden-
tical manner (5 minutes at 120 beats/min). During this pac-
ing period, the patient smoked a cigarette. Variables were
recorded during the final 2 minutes of this pacing/smoking
period. In each patient, therefore, coronary sinus blood flow
was quantitated before and during atrial pacing alone and
before and during atrial pacing and smoking. To exclude
the possibility that one pacing period exerted a prolonged
effect on the subsequent one, the order in which pacing and
pacing/smoking were performed was alternated so that in
five patients, pacing alone was performed first and pac-
ing/smoking was performed second; in the remaining five,
pacing/smoking was accomplished first and was followed
(15 minutes later) by pacing alone.
Analysis of data. On the basis of the results of selective
coronary arteriography, these 10 patients were divided into
those with (n = 5) or without (n = 5) greater than 70%
narrowing of the proximal third of the left anterior descend-
ing or circumflex coronary artery, or both. For each group,
the increase in heart rate-systolic pressure product and coro-
nary sinus blood flow during pacing alone was compared
with that during pacing/smoking with a paired t test. The
differences in coronary sinus blood flow between pacing
and pacing/smoking in the two groups were compared with
Student's t test (27). A P value of less than 0.05 was con-
sidered significant.
Results
Hemodynamic and Serologic Responses to Smoking
The 17 control patients had smoked an average of 43 ±
18 pack-years of cigarettes. Selective coronary arteriog-
raphy revealed atherosclerotic one vessel coronary artery
disease in five, two vessel disease in six and three vessel
disease in six. In these 17 patients, no hemodynamic vari-
able changed from baseline to repeat measurement 8 to 10
minutes later (Table I, Fig. 1 and 2), and the values for
thromboxane B2 and 6-keto-PGF1a in blood obtained from
coronary sinus blood samples were similar at baseline and
repeat study (Table I).
The 21 patients who smoked two cigarettes over an 8 to
10 minute period had smoked an average of 41 ± 25 pack-
years of cigarettes. Selective coronary arteriography re-
vealed one vessel coronary artery disease in 6, two vessel
disease in 3 and three vessel disease in 12. Of these 21
patients, 11 had greater than 70% stenoses of the proximal
left anterior descending or circumflex coronary artery, or
both, whereas the other 10 had stenoses of the more distal
portions of these arteries. In both groups, smoking induced
a significant increase in heart rate, heart rate-systolic pres-
sure product, left ventricular dP/dt and cardiac output (Table
I). In the 10 patients without proximal left coronary artery
stenoses, smoking caused an increase (average 20 ± 20
mllmin) in coronary sinus blood flow (p = 0.011) (Fig. I)
and a decrease (average 0.14 ± 0.19 mm Hg/ml per min)
(p = 0.045) in coronary vascular resistance (Fig. 2). In
contrast, neither coronary blood flow nor resistance was
modified significantly by smoking in the 11 patients with
proximal stenoses of the left coronary artery (Table I, Fig.
I and 2). Coronary sinus blood flow increased only 9 ±
29 mllmin and coronary vascular resistance changed 0.00
± 0.14 mm Hg/ml per min during smoking (coronary sinus
blood flow p = 0.032 and coronary vascular resistance p
= 0.078 in comparison with the 10 patients without prox-
imal left coronary artery stenoses). Finally, smoking in-
duced either no change or a decrease in coronary sinus blood
flow in 6 of the II patients with proximal left coronary
artery stenoses, but in none of the 10 with more distal
stenoses (chi-square = 7.636, P = 0.006).
lACC Vol. 4, No.5
November 1984:964-71
Table 1. Hemodynamic and Serologic Responses to Cigarette Smoking
N1COD ET AL.
CIGARETTE SMOKING AND CORONARY BLOOD FLOW
967
Smokers With Proximal LCA Smokers Without Proximal LCA
Control Subjects (n = 17) Stenoses (n = II) Stenoses (n = 10)
Variable Baseline Repeat Baseline Repeat Baseline Repeat
Heart rate (beats/min) 78 ± 15 77 ± 14 79 ± 10 84 ± 11* 70 ± II 76 ± 12*
Systolic blood pressure (mm Hg) 125 ± 24 126 ± 23 129 ± 25 131 ± 24 125 ± 32 131 ± 31
Heart rate-systolic pressure 9.6 ± 2.0 9.6 ± 2.0 lOA ± 2.7 11.1 ± 2.8* 8.7 ± 2.8 10.0 ± 3.3*
product (X 103)
Left ventricular end-diastolic 19 ± 7 21 ± 6 17± 10 17 ± 10 16 ± 5 16 :!: 4
pressure (mm Hg)
Left ventricular dP/dt (mm Hg/s) 1,269 ± 347 1,289 :!: 354 1,292 :!: 327 1,394 :!: 438* 1,222 :!: 337 1,444 :!: 538*
Cardiac output (liters/min) 4.74 :!: 1.07 4.82 :!: 1.23 4.76 :!: 0.93 5.14 :!: 1.19* 5.26 :!: 0.73 6.05 :!: 1.14*
Coronary sinus blood flow 102 :!: 31 104 :!: 33 117 :!: 39 125 :!: 47 99 :!: 44 119 :!: 52*
(ml/min)
Coronary vascular resistance 0.97 :!: 0.36 0.88 :!: 0040 0.85 ± 0.17 0.85 :!: 0.19 1.10 :!: 0047 0.96 :!: 0044*
(mm Hg/ml per min)
Coronary sinus thromboxane B2 123 :!: 125 131 :!: 103 153 :!: 133 174 :!: 117 113 :!: 90 163 :!: 99
(pg/ml)
Coronary sinus 6 keto-PGF 1a 6 :!: 7 9 :!: 10 5 :!: 7 4 :!: 5 2 :!: 3 5 :!: 7
(pg/ml)
*p < 0.05 in comparison with baseline. All values are mean:!: standard deviation. LCA = left coronary artery.
In the 21 patients in whom the hemodynamic and sero-
logic responses to smoking were assessed, there was no
relation between the changes in coronary sinus blood flow
and the amount of cigarettes that the patients had smoked
(in pack-years) (r = 0.12, P = 0.61). Similarly, there was
no relation between the smoking-induced alterations in coro-
nary blood flow and the changes in the coronary sinus con-
centrations of thromboxane B2 and 6-keto-PGF 1o"
Table 2. Hemodynamic Responses to Pacing and Pacing/Smoking
Variable
Pacing alone
Heart rate-systolic pressure product before
pacing (X 103)
Heart rate-systolic pressure product during
pacing (X 103)
Coronary sinus blood flow (ml/min) before
pacing
Coronary sinus blood flow (mllmin) during
pacing
Average increase in coronary sinus blood
flow (ml/min) during pacing
Pacing/smoking
Heart rate-systolic pressure product before
pacing/smoking (X 103)
Heart rate-systolic pressure product during
pacing/smoking (X 103)
Coronary sinus blood flow (mllmin) before
pacing/smoking
Coronary sinus blood flow (mllmin) during
pacing/smoking
Average increase in coronary sinus blood
flow (mil min) during pacing/smoking
Patients With Proximal
LCA Stenoses
(n = 5)
9.7 :!: 1.2
14.5 ± 1.5*
89 :!: 18
128 ± 39*
39 ± 24
9.1 ± 0.9
14.1 :!: 1.2*
85 :!: 33
121 :!: 40*
36 ± 16
Patients Without Proximal
LCA Stenoses
(n = 5)
10.1 :!: 0.7
16.5 :!: 3.6*
112 :!: 68
139 :!: 84*
26 ± 29
10.3 ± 0.8
16.7 :!: 4.0*
106 :!: 56
151 :!: 65*
45 :!: 2It
*p < 0.05 in comparison with values before pacing or pacing/smoking; tp = 0.018 in comparison with
the average increase during pacing alone. All values are mean ± standard deviation; LCA = left coronary
artery.
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Figure 1. Coronary sinus blood flow (in mllmin) be-
fore (B) and after (A) an 8 to 10 minute period without
smoking (left panel)(control group) and before (B) and
after smoking (5) in patients with (middle panel) and
without (right panel) proximal left coronary artery
stenoses. Each line represents the data from one pa-
tient. and the mean values :!: standard deviations are
displayed on either side of each set of lines. In the 17
control patients (left panel ), coronary sinus blood flow
did not change from baseline to the second measure-
ment. In the II smokers with severe proximal left
coronaryarterystenoses(middle panel) , smoking caused
no significant change in coronary sinus blood flow. In
contrast, in the 10smokers without such stenoses (right
panel ), smoking induced a significant increase in coro-
nary sinus blood flow (p = 0.011) .
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Influence of Smoking on Pacing-Induced Increases
in Coronary Sinus Blood Flow
These 10 patients had smoked 41 ± 24 pack-years of
cigarettes. Selective coronary arteriography revealed one
vessel disease in four , two vessel di sease in five and three
vessel disease in one . Stenosis of the proximal left anterior
descending or circumflex coronary artery , or both , was pres-
ent in five and absent in five . The heart rate-systolic pressure
product before pacing and pacing/smoking was similar in
the two groups of patients , and in both groups the rate-
pre ssure product increased similarly during pacing and pac-
ing/smoking (Table 2). In tho se without proximal left coro-
nary artery stenoses, coronary sinu s blood flow increased
26 ± 29 mllmin during pacing and 45 ± 21 mllmin during
pacing/smoking (p = 0.018) (Table 2, Fig . 3). In contrast .
in the five patients with proximal left anterior descending
or circumflex artery stenoses , or both , coronary sinu s blood
flow increased 39 ± 24 mllmin during pacing alone. but
only 36 ± 16 mllmin during pacing/smoking (p = NS)
(Table 2. Fig . 3) .
Discussion
Systemic and coronary hemodynamic responses to
cigarette smoking in long-term smokers with athero-
sclerotic coronary artery disease. In patients with and
without atherosclerotic coronary artery disease, cigarette
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Figure 2. Coronary vascular resistance (in mm
Hg/ml per min) before (B) and after (A) an 8 to
10 minute period without smoking (left panel )
(control group) and before (B) and after smoking
(S ) in patients with (middle panel ) and without
(right panel) proximal left coronary artery sten-
oses. Each line represents the data from one pa-
tient, and the mean values :!: standard deviations
are displayed on either side of each set of lines.
In the 17 control patients (left panel ), coronary
vascular resistance did not change from baseline
to the second measurement. In the II smokers
with severe proximal left coronary artery stenoses
(middle panel) , smoking caused no significant
change in vascular resistance. In contrast, in the
10 smokers without severe proximal left coronary
artery narrowings (r ight panel ), smoking induced
a significant decrease in coronary vascular resis-
tance (p = 0.045).
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Figure 3. Change in coronary sinus blood flow from baseline to
pacingalone (P) and pacingand concomitant smoking (P/S) in the
10patients in whomthese maneuvers were performed 15 minutes
apart. Eachlinerepresents the data fromone patient, and the mean
values ± standard deviations are displayed on either side of each
set of lines. In the five patients without severe proximal left coro-
naryarteryproximal narrowings (right panel), the change in coro-
nary sinus blood flow during pacing/smoking was greater (p =
0.018) than during pacing alone. In contrast, in the five patients
with proximal stenoses (left panel), the change in coronary blood
flow during pacing/smoking was similar to that during pacing
alone.
smoking increases the heart rate-systolic pressure product,
a reflector of myocardial oxygen demands (5,9-16). The
response of other hemodynamic variables to smoking ap-
pears to be related to the presence or absence of athero-
sclerotic coronary artery disease. In patients without such
disease, smoking augments cardiac output, left ventricular
performance and coronary blood flow (5-8, 10-12). In pa-
tients with atherosclerotic coronary artery disease, the effect
of cigarette smoking on these variables has not been suf-
ficiently clarified. Some studies (8) have demonstrated that
smoking increases them, others (7,10,14,16,28) have shown
that it exerts no discernible effect and still others (17-19)
have suggested that it causes a decrease in coronary blood
flow and a commensurate increase in coronary vascular re-
sistance, especially in those with severe proximal stenosis
of the left coronary artery (18). Our data demonstate that
1) cigarette smoking augments cardiac output, left ventric-
ular dP/dt and heart rate-systolic pressure product in long-
term smokers with coronary artery disease (Table I), but
2) the response of coronary sinus blood flow and coronary
vascular resistance to smoking is heterogeneous and depends
on the presence or absence of severe atherosclerotic nar-
rowings of the proximal left anterior descending or circum-
flex coronary artery, or both.
Role of site and extent of coronary atherosclerosis.
Klein et al. (18) previously demonstrated that the presence,
severity and location of coronary artery stenoses may alter
the coronary vascular response to smoking; three of their
five patients with 75% or greater left main or proximal left
anterior descending stenoses exhibited a modest decrease in
coronary blood flow during smoking. Our data are in agree-
ment with these observations. Of the 21 patients who smoked
during the study, 11 had severe (> 70%) stenoses of the
proximal left anterior descending or circumflex coronary
artery, or both, 6 (55%) of whom demonstrated no change
or a decrease in coronary sinus blood flow during smoking.
In contrast, in the 10 patients with more distal coronary
artery stenoses, coronary sinus blood flow increased during
smoking in all (chi-square = 7.636, P = 0.006). Thus, the
influence of cigarette smoking on coronary blood flow and
resistance is related to the location and extent of athero-
sclerotic coronary artery disease.
In an attempt to determine if smoking, in some way,
alters the response of coronary blood flow to increased myo-
cardial oxygen demands, we evaluated the response of coro-
nary sinus blood flow to rapid atrial pacing both with and
without concomitant smoking in 10 patients with athero-
sclerotic coronary artery disease, 5 of whom had proximal
stenoses of the left coronary artery. In those without prox-
imal stenoses, pacing induced a modest increase in coronary
sinus blood flow, whereas pacing/smoking caused an even
greater increase (p = 0.018) (Table 2, Fig. 3). In contrast,
in the five patients with proximal left coronary artery sten-
oses, the increase in coronary sinus blood flow induced by
pacing/smoking was similar to that which occurred during
pacing alone. Thus, in patients with severe atherosclerotic
narrowings of the proximal left anterior descending or cir-
cumflex coronary artery, or both, smoking causes no aug-
mentation of coronary blood flow when it is performed in
conjunction with other provocative maneuvers such as rapid
atrial pacing.
Serologic responses to cigarette smoking in long-term
smokers with atherosclerotic coronary artery dis-
ease. Previous studies (21) suggested that long-term ex-
posure to cigarette smoke augments platelet aggregability
and that short-term exposure renders circulating platelets
more responsive to various aggregatory stimuli such as aden-
osine diphosphate. In the experimental animal, nicotine in-
hibits the formation of prostacyclin by vascular endothelial
cells, resulting in platelet hyperaggregability (22-24). In
addition, smoking attenuates the hemodynamic alterations
induced by the infusion of prostacyclin (29). More recent
investigations (19) demonstrated that the coronary sinus
concentrations of 6-keto-PGF l o in long-term smokers are
lower than those of nonsmokers, but that short-term cigarette
smoking does not alter the coronary sinus concentrations of
thromboxane B2 or 6-keto-PGF1a . Our data are in agreement
with this observation (Table 1). The individual alterations
in coronary sinus blood flow induced by smoking had no
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clear relation to the individual changes in the concentration
of thromboxane B2 or 6-keto-PGFlo in coronary sinus blood.
Limitations of present study. In this study, we mea-
sured total coronary sinus blood flow during cigarette smok-
ing, but did not assess its effects on regional myocardial
blood flow. Although smoking causes an increase in total
flow in some patients, its effects on regional flow are not
defined. It is conceivable that cigarette smoking induces a
redistribution of myocardial blood flow so that total flow is
augmented, but flow to certain regions (those supplied by
a severely narrowed coronary artery) is reduced. In support
of this possibility, 6 of the II patients with severe proximal
stenoses of the left coronary artery had no change or a
decrease in coronary sinus blood flow during smoking. As
a result, some patients may develop myocardial ischemia
during smoking or at least may experience a smoking-in-
duced decrease in anginal threshold.
Clinical implications. In long-term smokers with ath-
erosclerotic coronary artery disease, cigarette smoking aug-
ments myocardial oxygen demands, but the response of
coronary blood flow is heterogeneous. On the one hand,
individuals without severe stenoses of the proximal left coro-
nary artery consistently demonstrate an increase in coronary
sinus blood flow and a decrease in coronary vascular resis-
tance during smoking. On the other hand, some patients
with severe stenoses of the proximal portions of the left
coronary artery demonstrate no change or a decrease in
coronary sinus blood flow as well as an increase in coronary
vascular resistance during smoking. Thus, the effect of cig-
arette smoking on coronary blood flow appears to be influ-
enced by the location and severity of underlying athero-
sclerotic coronary artery disease. As suggested previously
by Klein et al. (18), smoking may increase coronary artery
tone at the site of severe atherosclerotic narrowings. In
patients whose stenoses are located proximally, such en-
hanced tone is likely to cause a decrease in total coronary
sinus blood flow and a commensurate increase in calculated
coronary vascular resistance.
We acknowledge the skilled technical assistance of Sarah Hawkins, Randy
Christian, Nancy Smith, Milton Brady and Mary Beth Santowski.
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